SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Angiology
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
0003319708314249v1
60/1/50    most recent
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Ziakas, A.
Right arrow Articles by Parharidis, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ziakas, A.
Right arrow Articles by Parharidis, G.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
*Genetics Home Reference
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Ceruloplasmin is a Better Predictor of the Long-Term Prognosis Compared With Fibrinogen, CRP, and IL-6 in Patients With Severe Unstable Angina

Antonios Ziakas, MD

1st Cardiology Department, AHEPA, University Hospital, Thessaloniki, Greece, aziakas{at}med.auth.gr

Stavros Gavrilidis, MD

1st Cardiology Department, AHEPA, University Hospital, Thessaloniki, Greece

Efthimia Souliou, MD

1st Cardiology Department, AHEPA, University Hospital, Thessaloniki, Greece

George Giannoglou, MD

1st Cardiology Department, AHEPA, University Hospital, Thessaloniki, Greece

Ioannis Stiliadis, MD

1st Cardiology Department, AHEPA, University Hospital, Thessaloniki, Greece

Haralambos Karvounis, MD

1st Cardiology Department, AHEPA, University Hospital, Thessaloniki, Greece

George Efthimiadis, MD

1st Cardiology Department, AHEPA, University Hospital, Thessaloniki, Greece

Sotirios Mochlas, MD

1st Cardiology Department, AHEPA, University Hospital, Thessaloniki, Greece

M. Arvanitidou Vayona, MD

1st Cardiology Department, AHEPA, University Hospital, Thessaloniki, Greece

Apostolos Hatzitolios, MD

1st Cardiology Department, AHEPA, University Hospital, Thessaloniki, Greece

Christos Savopoulos, MD

1st Cardiology Department, AHEPA, University Hospital, Thessaloniki, Greece

Ifigenia Pidonia, MD

1st Cardiology Department, AHEPA, University Hospital, Thessaloniki, Greece

George Parharidis, MD

1st Cardiology Department, AHEPA, University Hospital, Thessaloniki, Greece

Background. We investigated the time course and prognostic value of fibrinogen (Fib), C-reactive protein (CRP), interleukin-6 (IL-6), and ceruloplasmin (CP) in patients with severe unstable angina. Methods. All 4 substances were measured on admission and after 6, 12, 24, 48, and 72 hours, and after 7 days and 6 months in 40 patients with Braunwald's classification class IIIB unstable angina. Results. All recorded substances increased significantly; 15 patients had cardiovascular events during hospitalization and 11 patients during follow-up. The time course and the mean values of Fib, CRP, and IL-6 were similar in patients with and without complications both during hospitalization and follow-up. However, CP levels from 6 hours until 6 months were significantly higher in patients with complications during follow-up (P < .05). Conclusions. Fib, CRP, IL-6, and CP levels alter in patients with severe unstable angina. However, only CP levels were related to 12-month follow-up prognosis.

Key Words: fibrinogen • C-reactive protein • interleukin-6 • ceruloplasmin • severe unstable angina • prognosis

This version was published on February 1, 2009

Angiology, Vol. 60, No. 1, 50-59 (2009)
DOI: 10.1177/0003319708314249


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement